stereotactic ablative radiotherapy (SABR)

Brain metastases from kidney cancer treated with first-line therapies

By Sharon Deveson Kell|2023-04-14T10:25:34+00:0014 Apr 2023|Drug treatments, Surgery|

A recent study looked at the outcomes of patients with [...]

Comments Off

5-year outcomes after SABR for primary kidney cancer

By Sharon Deveson Kell|2022-11-30T08:21:18+00:0030 Nov 2022|Surgery|

Stereotactic ablative body radiotherapy (SABR) uses an intense beam of [...]

Comments Off

Stereotactic ablative radiotherapy for kidney cancer metastases outside the brain

By Sharon Deveson Kell|2022-10-17T08:53:17+00:0017 Oct 2022|Surgery|

Stereotactic ablative radiotherapy (SABR) is mostly used for the treatment [...]

Comments Off

Role of stereotactic ablative body radiotherapy in kidney cancer

By Sharon Deveson Kell|2022-08-23T13:35:44+00:0023 Aug 2022|Surgery|

Stereotactic ablative body radiotherapy (SABR) is a procedure that uses [...]

Comments Off

EIKCS 2022: Radiotherapy for kidney cancer

By Sharon Deveson Kell|2022-04-26T07:22:12+00:0026 Apr 2022|Drug treatments, Surgery|

At the European International Kidney Cancer Symposium (EIKCS) in Antwerp, [...]

Comments Off

Stereotactic radiation can slow progression of kidney cancer

By Sharon Deveson Kell|2022-01-05T08:28:05+00:005 Jan 2022|Surgery|

A new study from the USA shows that highly focused [...]

Comments Off

NHS accelerates the launch of stereotactic ablative radiotherapy

By Sharon Kell|2020-06-12T14:56:30+00:0012 Jun 2020|Uncategorized|

In order to offer more convenient and potentially safer [...]

Comments Off

Role of stereotactic ablative radiotherapy for primary renal cell carcinoma

By Sharon Kell|2019-07-23T08:05:17+00:0023 Jul 2019|Surgery|

This paper reviews the use of stereotactic ablative radiotherapy (SABR) [...]

Comments Off

Role of stereotactic ablative radiotherapy (SABR) for kidney cancer

By Sharon Kell|2019-07-03T08:39:40+00:003 Jul 2019|Surgery|

This systematic review and meta-analysis of the literature for the [...]

Comments Off

ASTRO 2018: Stereotactic radiotherapy proves safe and effective for kidney cancer patients with one kidney

By Sharon Kell|2018-10-29T15:07:10+00:0029 Oct 2018|Surgery|

The results from a study shows stereotactic ablative radiotherapy (SABR) [...]

Comments Off

Address

Action Kidney Cancer

11th Floor
3 Piccadilly Place
Manchester M1 3BN

Helpline

0800 121 8721
Email Us

About Action Kidney Cancer

We are the UK’s largest and most active patient-led kidney cancer charity. Whether you are a patient, survivor or someone you know has been diagnosed with kidney cancer, you have come to the right place to find support and information, and to be part of a caring and knowledgeable community of people: We are here to help you.

Registered charity in England, Wales (1164238), and Scotland (SC051330).

© Copyright Action Kidney Cancer 2021

Links

Branding by Kingswood Marketing

Policies

Website Policies

Complaints Policy

Equal Opportunities Policy

Information Governance Policy

Social Media Policy

Follow

Web Design by Douglass Digital

Helpline: 0800 121 8721

support@actionkidneycancer.org